enVVeno Medical (NVNO) Cash from Investing Activities (2017 - 2026)

enVVeno Medical's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 46.74% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $13.4 million, a 209.47% increase from a year earlier, with the FY2025 full-year figure at $15.9 million, up 1087.72% from the prior year.
• Cash from Investing Activities declined to $2.8 million in Q1 2026 per NVNO's latest filing, from $4.2 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $7.0 million in Q2 2023 and bottomed at -$38.3 million in Q2 2022.
• The 5-year median for Cash from Investing Activities is $2.8 million (2023), against an average of -$1.3 million.
• Biggest YoY gain for Cash from Investing Activities was 8586.15% in 2022; the steepest drop was 30064.57% in 2022.
• Year by year, Cash from Investing Activities stood at $5.5 million in 2022, then sank by 501.45% to -$22.1 million in 2023, then jumped by 50.07% to -$11.1 million in 2024, then jumped by 137.83% to $4.2 million in 2025, then sank by 33.76% to $2.8 million in 2026.
• Per Business Quant, the three latest NVNO Cash from Investing Activities figures stand at $2.8 million (Q1 2026), $4.2 million (Q4 2025), and $3.7 million (Q3 2025).